P-Glycoprotein Activity in Steroid-Responsive vs. Steroid-Resistant Nephrotic Syndrome

Indian Journal of Pediatrics

Volumn 83, Issue 11, 2016, Pages 1222-1226

  Badr, Hassan S ^a   El Hawy, Mahmoud A ^a   Helwa, Mohammed A ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Nephrotic syndrome; P gp; Steroid resistant; Steroid sensitive

Indexed keywords

CHOLESTEROL; CREATININE; CYCLOSPORIN; MULTIDRUG RESISTANCE PROTEIN; PREDNISONE; PROTEIN; RHODAMINE 123; SERUM ALBUMIN; UREA; ABC TRANSPORTER SUBFAMILY B; GLUCOCORTICOID; MULTIDRUG RESISTANCE PROTEIN 1; STEROID;

ALBUMIN BLOOD LEVEL; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONCENTRATION RESPONSE; CONGENITAL NEPHROTIC SYNDROME; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SENSITIVITY; DRUG UPTAKE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; FUNCTIONAL ASSESSMENT; HUMAN; INCUBATION TIME; LABORATORY TEST; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NEPHROTIC SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; REMISSION; SCHOOL CHILD; STEROID SENSITIVE NEPHROTIC SYNDROME; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; METABOLISM;

ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY B; ATP-BINDING CASSETTE, SUB-FAMILY B, MEMBER 1; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; NEPHROTIC SYNDROME; STEROIDS;

EID: 84969802941     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-016-2142-y     Document Type: Article

References (25)

1. Banaszak B, Banaszak P, Adamczyk P, Ziora K. First detection of pediatric nephrotic syndrome: clinical characteristics of a steroid-sensitive and steroid-resistant patient. (In Polish) Przegl Pediatr. 2011;41:147–51.
2. Jaroniec M, Ostalska-Nowicka D, Åmiech M, et al. Evaluation of single nucleotide polymorphism in direct vicinity of recognized mutations in NPHS2 gene in children with nephrotic syndrome. (In Polish) Nefrol Dial Pol. 2010;14:111–5.
3. Swierczewska M, Ostalska-Nowicka D, Kempisty B, et al. Molecular basis of mechanisms of steroid resistance in children with nephrotic syndrome. Acta Biochim Pol. 2013;60:339–44.
4. Che R, Zhang A. Mechanisms of glucocorticoid resistance in idiopathic nephrotic syndrome. Kidney Blood Press Res. 2013;37:360–78.
5. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol. 1997;40:S3–8.
6. Hinoshita E, Uchiumi T, Taguchi K, et al. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res. 2000;6:2401–7.
7. Klimecki WT, Futscher BW, Grogan TM, et al. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood. 1994;83:2451–8.
8. Drigo I, Piscianz E, Valencic E, et al. Selective resistance to different glucocorticoids in severe autoimmune disorders. Clin Immunol. 2010;134:313–9.
9. Li H, Yan Z, Ning W, et al. Using rhodamine 123 accumulation in CD8+ cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo. J Biomed Biotechnol. 2011;2011:281651.
10. A Report of the International Study of Kidney Disease in Children. The primary nephrotic syndrome in children: identification of patients with minimal change nephrotic syndrome from initial response to prednisolone. J Pediatr. 1981;98:561–4.
11. A report of the ISKDC early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr. 1982;101:514–8.
12. Report of Arbeitsgemeinschaft fur pediatrische Nephrologie. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Arch Dis Child. 1987;62:1102–6.
13. Habashy D, Hodson EM, Craig JC. Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol. 2003;18:906–12.
14. Wasilewska A, Zoch-Zwierz W, Pietruczuk M, et al. Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol. 2006;21:1274–80.
15. Meijer OC, de Lange EC, Breimer DD, et al. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology. 1998;139:1789–93.
16. Türkmen M, Torun-Bayram M, Soylu A, et al. The relationship between renal P-glycoprotein expression and response to steroid therapy in childhood nephrotic syndrome. Turk J Pediatr. 2013;55:260–5.
17. Wasilewska A, Zoch-Zwierz W, Pietruczuk M. Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor. Eur J Pediatr. 2007;166:447–52.
18. Funaki S, Takahashi S, Wada N, et al. Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome. Pediatr Int. 2008;50:159–61.
19. Prasad N, Jaiswal AK, Agarwal V, et al. Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in childhood nephrotic syndrome: a longitudinal study. Cytokine. 2015;72:190–6.
20. Tsujimura S, Saito K, Nakayamada S, et al. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52:1676–83.
21. Sakaeda T, Nakamura T, Okumura K. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy. Curr Top Med Chem. 2004;4:1385–98.
22. Youssef DM, Elbehidy RM, Abdelhalim HS, et al. Soluble interleukine-2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephrotic syndrome. Iran J Kidney Dis. 2011;5:154–61.
23. Jafar T, Prasad N, Agarwal V, et al. MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children. Nephrol Dial Transplant. 2011;26:3968–74.
24. Cizmarikova M, Podracka L, Klimcakova L, et al. MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results. Med Sci Monit. 2015;21:59–68.
25. Youssef DM, Attia TA, El-Shal AS, et al. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids. Gene. 2013;530:201–7.